20.06.2023 • NewsSolvayNovecarearoma chemicals

Solvay Details Business Split

Belgian chemical company Solvay is splitting up into two separate entities.

Further to its announcement in March 2022 that it was exploring options to split into two, Solvay has now released the names of the new companies.

The first — dubbed EssentialCo — will retain the Solvay name and comprise the Brussels-based group’s soda ash, peroxides, silica, Coatis and Special Chem businesses that together generated about €5.6 billion in net sales last year.

SpecialtyCo — comprising specialty polymers, composites, Novecare, aroma, technology solutions, oil & gas, as well as the four growth platforms in batteries, green hydrogen, thermoplastic composites and renewable materials and biotechnology — will bear the name Syensqo. The businesses within Syensqo generated net sales of about €7.9 billion in 2022.

CEO Ilham Kadri commented: “Solvay has a 160-year legacy that will be passed on for generations to come and the names of our new companies reflect this perfectly.” She added that Solvay will create and deliver essential solutions in housing health, nutrition and mobility, while Syensqo “will be a company of explorers who will usher in breakthroughs that will advance humanity.”

 

Further to its announcement in March 2022 that it was exploring options to...
Further to its announcement in March 2022 that it was exploring options to split into two, Belgian chemical company Solvay has released the names of the two companies.

These breakthroughs would be in next-generation batteries for electric vehicles, bio-based solutions, natural ingredients and circular solutions, among others.

Explaining the reasoning behind the Syensqo name, Solvay said the S and Y link to the first and last letters in Solvay, the EN is a nod to founder Ernest Solvay, SYENS refers to Solvay’s scientific heritage, Q points to Solvay’s first conference in 1911 that it said laid the foundations for quantum physics, and QO is for company.

The new names will take effect once the separation has completed, which Solvay said is on track for December 2023.

Author: Elaine Burridge, Freelance Journalist

Company

Logo:

Solvay

Rue du Prince Albert 33
1050 Bruxelles
Belgium

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.